TALZENNA talazoparib (as tosilate) 0.35 mg capsule bottle

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 970027055cb4c0a7
Product Name: TALZENNA talazoparib (as tosilate) 0.35 mg capsule bottle
Artg Id: 407813
Artg Name: TALZENNA talazoparib (as tosilate) 0.35 mg capsule bottle
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2024-08-14
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/b7e3ff96ba62571f0798cc5c73cff4db.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/9445f060fbd3575b617afaffd04a5678.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

970027055cb4c0a7

Type

Standard